Skip to main content
Menu
US

ValiScreen Human Chemokine CCR7 Cell Line, CHO-K1 Cells

Stable, recombinant ValiScreen® cell line expressing the Chemokine receptor CCR7, human recombinant in CHO-K1 host cells.

For research use only. Not for use in diagnostic procedures. Cell Line Terms and Conditions must be accepted before orders are placed. Additional agreement needed for commercial use. Click here.

Feature Specification
Application cAMP
Drug Discovery & Development
G-Alpha Natural Receptor Gi/Go
Special Ordering Information Requires accepted Terms and Conditions. Additional agreement needed for commercial use.
Validation Binding
cAMP
GTPγS

Stable, recombinant ValiScreen® cell line expressing the Chemokine receptor CCR7, human recombinant in CHO-K1 host cells.

For research use only. Not for use in diagnostic procedures. Cell Line Terms and Conditions must be accepted before orders are placed. Additional agreement needed for commercial use. Click here.

Overview

Revvity's ValiScreen cell lines are provided in two vials of frozen cells, each containing ~2.5 x 106 cells. Detailed product information as well as recommended cell culture conditions and validation assay date are available each cell line.

Clonal selection Revvity's ValiScreen cell lines is carried out with receptor binding. High and low expressors are n tested and selected optimal binding and functional response according to receptor specific transduction pathway.

Revvity’s ValiScreen cell lines require accepted cell line Terms and Conditions prior to order processing. Additional agreement needed for commercial use. Please use link above to accept Terms and Conditions or to request an agreement for commercial use.

Specifications

Application
cAMP
Drug Discovery & Development
Brand
ValiScreen
G-Alpha Natural Receptor
Gi/Go
Host Cell Line
CHO-K1
Host Species
Human
One Unit Contains
2.0 Vials
Product Group
Cell Line
Receptor
Chemokine
Second Messenger Release
GTP exchange
Shipping Conditions
Shipped in Dry Ice
Special Ordering Information
Requires accepted Terms and Conditions. Additional agreement needed for commercial use.
Target Class
GPCR
Therapeutic Area
Angiogenesis
Cardiovascular
Inflammation
Unit Size
5 million cells
Validation
Binding
cAMP
GTPγS

Resources

Are you looking for resources, click on the resource type to explore further.

1-2 of 2 Resources
Application Note Icon
Application Note
Characterizing chemokine receptor inhibitors with AlphaLISA SureFire Ultra, Alpha SureFire Ultra Multiplex and LANCE Ultra cAMP assays

The measurement of protein phosphorylation is a useful tool for measuring the modulation of receptor activation by both antibodies...

Brochure Icon
Brochure
Radioligand selection guide

Discover a comprehensive collection of GPCR cell lines, membrane preparations, and complementary radioligands designed to drive...

Scroll Icon